Clinical Trials of interest to cytokine & interferon researchers.
Interferon-α for TP53 Myeloid Malignancy Post Allo-HSCT
ClinicalTrials.gov ID NCT06130579
Sponsor: Peking University People’s Hospital
Information provided by Xiao-Jun Huang, Peking University People’s Hospital (Responsible Party)
Last Update Posted 2024-03-21
MITHRIDATE: Ruxolitinib Versus Hydroxycarbamide or Interferon as First Line Therapy in High Risk Polycythemia Vera (MITHRIDATE)
ClinicalTrials.gov ID NCT04116502
Sponsor: University of Birmingham
Information provided by University of Birmingham (Responsible Party)
Last Update Posted 2024-05-10
Effect of Low-dose Interferon-alfa2a on Peri-operative Immune Suppression (IPOS)
ClinicalTrials.gov ID NCT04798612
Sponsor: Zealand University Hospital
Information provided by Zealand University Hospital (Responsible Party)
Last Update Posted 2023-08-18
Related Articles
Clinical Trials for the week of August 7
Clinical Trials of interest to cytokine & interferon researchers Anti-tumor Necrosis Factor in Patients With Ulcerative Colitis in Clinical Remission: to Continue or Not? (BIOSTOP) ClinicalTrials.gov ID NCT03011268 Sponsor Helse Møre og Romsdal HF Information provided by Helse Møre og Romsdal HF (Responsible Party) Last Update Posted 2023-03-17 Evaluation of [READ MORE]
Clinical Trials for the week of August 21
Blocking TNF to Potentiate the ICI-dependent Immune Awakening in Melanoma (ATPIC) | Effectiveness of Zidovudine vs. Zidovudine Plus Alpha Interferon vs. Interferon for Treatment of HIV | Safety and Efficacy of Interferon-Gamma 1b in Patients With Candidemia [READ MORE]
Clinical Trials for the week of September 4
Pegylated Interferon Lambda for Treatment of COVID-19 Infection | Proportion of Clinical Improvement & Type 1 Interferon (IFN) Score Changes in Idiopathic Uveitis Patients With Interferon Gamma Release Assay (IGRA) Positive | Allogeneic Hematopoietic Cell Transplantation With Pegylated Interferon Alfa-2a for Primary and Secondary Myelofibrosis (ATIOM) [READ MORE]